ARGENT BIOPHARMA LIMITED ORD NPV (DI) financial statements, including revenue, expenses, profit, and loss
The total revenue of RGT for the last semiannual is 320.62 k GBP, and it's 15.71% lower compared to the previous semiannual. The net income of H1 24 is -3.78 M GBP.